CELEVAC 500MG TABLETS

Active substance: METHYLCELLULOSE

View full screen / Print PDF » Download PDF ⇩

Transcript
PRODUCT NAME:
PIP CODE:
COMPONENT:
FINISHED SIZE:
OPEN SIZE:
MARKET:
COMMODITY NO.:
PRODUCT SITE:
SCALE:
COLOURS:

Amdipharm UK Limited, Capital House,
85 King William Street,
London EC4N 7BL, UK
PL 20072/0045
102401/LLET/1

DATE:
FONT SIZE:
VERSION NO:
AMENDED BY:
PROJECT:

Celevac 500mg
Tablets
102401/LLET/1
Label/Leaflet
148 x 63 mm
305 x 63mm
Great Britain
TBC
E1759
100%
2758 C, 3275 C, Black, Braille &
Cutters
23/04/2014
8 pt
2
AMCo
CAC

REGULATORY AUTHORITY
APPROVAL CONFIRMATION
Confirmation that this artwork has been approved by
the appropriate market authority (if applicable, e.g.
MHRA, IMB, etc and that Amdipharm have license
approval to distribute this component for sale in the
relevent market.
Accept Artwork ................................................................
Reject Artwork .................................................................
Signature ..........................................................................
Name ................................................................................
Date ...................................................................................

PAGE 1 OF 1
Marketing Authorisation Holder:
Amdipharm UK Limited,
Capital House,
85 King William Street,
London EC4N 7BL, UK
Manufacturer responsible for release:
Dales Pharmaceuticals Limited,
Snaygill industrial estate, Keighley Road,
Skipton, North Yorkshire, Bd23 2rw,
United Kingdom
Celevac® is a registered trademark of
Amdipharm Mercury International Limited
This leaflet was last revised in April 2014.

Amdipharm UK Limited, Capital House,
85 King William Street,
London EC4N 7BL, UK
PL 20072/0045
102401/LLET/1

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web5)